Empirical Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,547	Closed	-$1.81M	–	702
2024 Q4	$1.81M	Buy	2,547 +474	+23%	+$398K	0.05%	209
2024 Q3	$2.18M	Buy	2,073 +179	+9%	+$199K	0.06%	180
2024 Q2	$1.99M	Sell	1,894 -5	-0.3%	-$4.85K	0.06%	184
2024 Q1	$1.83M	Buy	1,899 +232	+14%	+$221K	0.06%	187
2023 Q4	$1.46M	Buy	1,667 +196	+13%	+$161K	0.05%	202
2023 Q3	$1.21M	Buy	1,471 +119	+9%	+$93.5K	0.05%	208
2023 Q2	$971K	Buy	+1,352	New	+$1.04M	0.04%	230
2022 Q2	–	Sell	-1,161	Closed	-$811K	–	519
2022 Q1	$811K	Sell	1,161 -876	-43%	-$554K	0.04%	247
2021 Q4	$1.29M	Sell	2,037 -896	-31%	-$551K	0.06%	175
2021 Q3	$1.77M	Buy	2,933 +563	+24%	+$350K	0.1%	125
2021 Q2	$1.32M	Buy	2,370 +529	+29%	+$268K	0.08%	155
2021 Q1	$871K	Buy	1,841 +705	+62%	+$343K	0.07%	173
2020 Q4	$549K	Buy	+1,136	New	+$613K	0.04%	237